Stable Glucagon for Treatment of Hyperinsulinism
Stable Glucagon for Treatment of Hyperinsulinism
批准号:
9333693
负责人:
Steve Eisenberg
金额:
$13.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-18 至 2019-08-31
关键词:
AgitationAmino Acid SubstitutionBiological AssayBirthBlindnessCaringCerebral PalsyCessation of lifeChemicalsChildClinicalClinical ResearchClinical TrialsDNA Sequence AlterationDefectDiabetes MellitusDiffuseDiseaseEffectivenessEpilepsyFailureFamilyFluorescenceFormulationFutureGlucagonGlucagon ReceptorGlucoseGlucose Plasma ConcentrationGlutamineGoalsHigh Pressure Liquid ChromatographyHumanHyperinsulinismHypoglycemiaIn VitroIncidenceInfusion proceduresKineticsLeadLearning DisabilitiesLegal patentLength of StayLibrariesLifeLife StyleMedicalMonitorMutationNewborn InfantOperative Surgical ProceduresOutcomePancreatectomyPatient-Focused OutcomesPatientsPersistent Hyperinsulinemia Hypoglycemia of InfancyPhaseProcessProductionPropertyPumpRegulationResistanceSeriesSideSterilitySystemTechnologyTestingThermodynamicsTubeUnited Statesamino groupanalogbasechemical stabilitycostdeamidationdesigneffective therapyimprovedin vivoinsulin secretionlarge scale productionmilligrammouse modelphase 2 studypreventstability testingsubcutaneous
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT
A series of glucagon analogues will be designed, produced at milligram levels, tested for solution stability and
both in vitro and in vivo activity with the goal of providing a long term treatment for hyperinsulinism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金